The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1,5-Dimethyl-N-(2-(methylamino)-2-oxoethyl)-6-oxo-N-(2-phenylpropyl)-1,6-dihydropyridine-3-carboxamide ID: ALA4878603
PubChem CID: 164626663
Max Phase: Preclinical
Molecular Formula: C20H25N3O3
Molecular Weight: 355.44
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CNC(=O)CN(CC(C)c1ccccc1)C(=O)c1cc(C)c(=O)n(C)c1
Standard InChI: InChI=1S/C20H25N3O3/c1-14-10-17(12-22(4)19(14)25)20(26)23(13-18(24)21-3)11-15(2)16-8-6-5-7-9-16/h5-10,12,15H,11,13H2,1-4H3,(H,21,24)
Standard InChI Key: HZVLFNBTVSYMSI-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 27 0 0 0 0 0 0 0 0999 V2000
21.2538 -3.0459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2527 -3.8654 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.9607 -4.2744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6704 -3.8649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6675 -3.0423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9589 -2.6370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5460 -2.6374 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.9565 -1.8198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3787 -4.2724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3800 -5.0896 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.0858 -3.8627 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.5446 -4.2734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0848 -3.0455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7920 -2.6361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7910 -1.8189 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.4983 -1.4094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5002 -3.0438 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.7941 -4.2703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7952 -5.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0881 -5.4971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5035 -5.4951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5005 -6.3116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2080 -6.7191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9161 -6.3095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9123 -5.4881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2043 -5.0843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 2 0
6 8 1 0
4 9 1 0
9 10 2 0
9 11 1 0
2 12 1 0
11 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
14 17 2 0
11 18 1 0
18 19 1 0
19 20 1 0
19 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 355.44Molecular Weight (Monoisotopic): 355.1896AlogP: 1.69#Rotatable Bonds: 6Polar Surface Area: 71.41Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 0.98CX LogD: 0.98Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.86Np Likeness Score: -1.29
References 1. Rianjongdee F, Atkinson SJ, Chung CW, Grandi P, Gray JRJ, Kaushansky LJ, Medeiros P, Messenger C, Phillipou A, Preston A, Prinjha RK, Rioja I, Satz AL, Taylor S, Wall ID, Watson RJ, Yao G, Demont EH.. (2021) Discovery of a Highly Selective BET BD2 Inhibitor from a DNA-Encoded Library Technology Screening Hit., 64 (15.0): [PMID:34251219 ] [10.1021/acs.jmedchem.1c00412 ]